Inborn Errors of Amino Acid Metabolism

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 65

Inborn Errors

of
Amino Acid
Metabolism
Inborn errors of metabolism occur when
some enzyme involved in metabolism is
abnormal

The abnormality occurs due to a mutation


in gene encoding the enzyme

The affected enzyme may be absent or


deficient
Inborn errors may occur in metabolism of
all nutrients including amino acids

When an enzyme is absent or deficient,


metabolism of the concerned amino acid
becomes abnormal
Over 50 inborn errors of metabolism of
amino acids have been discovered

The clinical abnormalities may occur


due to:

Decreased synthesis of products

Accumulation of intermediates

Formation of alternate
metabolites
Many disorders result in
neurological abnormalities and mental
retardation

Early diagnosis and treatment can


prevent neurological abnormalities

Generally, the treatment comprises


restricted intake or exclusion of the
affected amino acid from the diet
Some relatively common inborn errors are:
• Primary hyperoxaluria
• Maple syrup urine disease (MSUD)
• Cystinuria
• Homocystinuria
• Phenylketonuria (PKU)
• Alkaptonuria
• Tyrosinaemia
• Albinism
• Histidinaemia
• Hartnup Disease
Primary hyperoxaluria

Primary hyperoxaluria is a disorder


of glyoxylate metabolism

Glyoxylate is formed from hydroxyproline

Normally, glyoxylate is transaminated


to glycine or is oxidised to formate
Glyoxylate is converted into oxalate when:

Glycine transaminase is deficient

Oxidation of glyoxylate is impaired

This leads to hyperoxaluria and recurrent


formation of oxalate stones in urinary tract
Maple syrup urine disease (MSUD)

This is a disorder of the branched-chain


amino acids, valine, leucine and isoleucine

Enzymes catalyzing the first two reactions


in the catabolism these are common
Branched-chain amino are
acids transaminated to -keto
acids first
oxidative
The -keto acids undergo
decarboxylation
Oxidative decarboxylation is catalysed by -
ketoisovalerate dehydrogenase

This enzyme is absent or deficient in MSUD


Valine Leucine lsoleucine

Branched-chain amino acid transaminase

a-Ketoiso­ a-Ketoiso­ a-Keto-p-methyl


valeric acid caproic acid valeric acid

a-Ketoisovalermle: ehydrogenase

lsobutyryl lsovaleryl a-Methylbutyryl
CoA CoA CoA
The enzyme deficiency leads to
accumu- lation and increased urinary
excretion of:

Branched chain amino acids

Their -keto acid derivatives

This imparts a typical odour to urine similar


to that of maple syrup or burnt sugar
The clinical signs and symptoms
appear within one week of birth

Lethargy, vomiting and aversion to


food are early signs

These are followed by severe


brain damage and ultimately death
The treatment consists of exclusion
of branched-chain amino acids from diet

This is required until the plasma levels fall


to normal

Thereafter, the intake is restricted so


as to maintain the plasma levels
A milder variant of maple syrup urine disease
is intermittent branched-chain ketonuria

In this, the decrease in enzyme activity is only


moderate

The signs and symptoms are milder


and appear much later

The excretion of branched-chain -keto acids


is intermittently increased
Cystinuria

There is a defect in tubular reabsorption


of cystine

Urinary excretion of cystine is increased

Being sparingly soluble, cystine deposits


in the kidneys and forms cystine stones

The defect also involves reabsorption


of lysine, arginine and ornithine
Homocystinuria

Cystathionine synthetase is severely


deficient in homocystinuria

This impairs the conversion of methionine


into cysteine

Homocysteine accumulates and is


converted into homocystine
Homocystine is made up of two
homo- cysteine molecules

Urinary excretion of homocystine


is increased

Plasma methionine and


homocysteine levels are increased
The clinical features of homocystinuria are:

Thrombotic phenomena

Osteoporosis

Dislocation of lenses in the eyes

Mental retardation

Ischaemic vascular disease


Accumulation of homocysteine causes:

Abnormal cross-linking of collagen

Abnormalities in the ground


substance of walls of blood vessels

Increased platelet adhesiveness


Dislocation of ocular lenses and
osteo- porosis occur due to abnormal
collagen

Thrombotic phenomena occur because


of abnormalities in the walls of blood
vessels
Increased platelet adhesiveness and
abnormal vessel walls cause:

Ischaemic heart disease

Cerebral thrombosis

Peripheral vascular disease


Ischaemic vascular diseases occur at a
young
age
Homocysteine has been described as the
new cholesterol because of its propensity to
cause ischaemic vascular diseases
Early diagnosis and treatment prevent
most of the clinical abnormalities

The treatment consists of a low-methionine,


high-cysteine diet

Pyridoxine supplements may be given


to activate the residual cystathionine
synthetase
Hyperhomocysteinaemia may occur due
to deficiency of some vitamins also,
specially folic acid and vitamin B12

In such cases, vitamin supplements


correct the abnormality
Phenylketonuria (PKU)

Phenylketonuria is the commonest inborn


error of amino acid metabolism

It has an incidence of about 1 in 10,000


live births

It was the first inborn error of amino acid


metabolism to be treated successfully by
diet manipulation
There is a block in the conversion
of phenylalanine into tyrosine in PKU

Two-thirds of the patients suffer from


PKU, type I

Phenylalanine hydroxylase is deficient


in PKU, type I

Several mutations have been observed


in the phenylalanine hydroxylase gene
One third of the cases
are due to a defect
in:

Dihydropteridine
reductase

or

Conversion of GTP into


tetrahydrobiopterin
The degree of defect is variable but it
is severe in majority of the patients

Plasma phenylalanine concentration


rises after ingestion of phenylalanine

When the level exceeds 1 mmol/L, alternate


metabolites of phenylalanine are formed
The alternate metabolites include:

Phenylpyruvate

Phenyl-lactate

Phenylacetate

Phenylacetylglutamine
Plasma concentration of phenylalanine is
raised in PKU

Plasma concentration of its


alternate metabolites is also raised

All these are excreted in urine


Some other amino acids share their transport
system with phenylalanine

A high phenylalanine level may inhibit


their intestinal absorption and renal tubular
reabsorption

Uptake of these amino acids by brain may


also be inhibited
Synthesis of myelin sheath is decreased

Synthesis of norepinephrine in brain


is decreased

Decreased availability of tyrosine


may decrease the synthesis of melanin
Clinical manifestations appear a few days or
weeks after birth

Developmental milestones are delayed

Motor hyperactivity and seizures occur

Skin is hypopigmented

Later on, there is severe mental


retardation
Early diagnosis (within 3 weeks of birth) and
treatment prevent the clinical abnormalities

Since phenylalanine is an essential


amino acid, it cannot be excluded from the
diet

A low-phenylalanine diet is given to keep the


plasma phenylalanine level below 6 mg/dl
Tyrosine cannot be synthesized
endo- genously in PKU

Hence, tyrosine becomes an


essential amino acid for patients with
PKU

Their diet needs tyrosine supplements


Dihydropteridine reductase is deficient in
PKU, type II

There is a block in the synthesis of tetra-


hydrobiopterin from GTP in PKU, type III

These two also result in


decreased conversion of phenylalanine
into tyrosine
Tetrahydrobiopterin is also required
for hydroxylation of tyrosine and
tryptophan

Deficiency of tetrahydrobiopterin
results in decreased synthesis of:

Dopamine, norepinephrine and


epinephrine from tyrosine

Serotonin and melatonin


from
tryptophan
The clinical abnormalities in phenyl-
ketonuria, types II and III:

Are more severe

Appear early

Do not improve despite


diet manipulation
Alkaptonuria

Alkaptonuria is an inborn error of tyrosine


metabolism

It is due to absence of homogentisate


oxidase

Homogentisate, an intermediate in cata-


bolism of tyrosine, cannot be metabolised
further
Homogentisate is excreted in urine

Freshly voided urine is normal in colour

Urine becomes dark on exposure to air


due to oxidation of homogentisate by
oxygen
Homogentisate and its oxidation product
form polymers that bind to collagen

This leads to generalized pigmentation


of connective tissues (ochronosis)

Chemical irritation of collagen causes


degenerative changes in connective tissue

Defective cross-linking of collagen also


adds to the degeneration
Damage to joint cartilages causes arthritis
(ochronotic arthritis)

Arthritis usually occurs in hip, knee


and shoulder joints and vertebral column

Pigmented spots may be seen on


sclera and ears
Treatment of alkaptonuria is symptomatic

Ascorbic acid supplements have


been tried but without much success
Tyrosinaemia

This is another inborn error of


tyrosine metabolism

Plasma tyrosine level is increased


in tyrosinaemia

Tyrosine and its metabolites are excreted


in urine
Two distinct genetic defects can
cause tyrosinaemia

Deficiency of
fumarylacetoacetate hydrolase causes
tyrosinaemia, type I

Deficiency of tyrosine transaminase


causes tyrosinaemia, type II
Tyrosinaemia, type I causes neurological
abnormalities, liver damage and renal
tubular dysfunction

Tyrosinaemia, type II affects eyes


and skin
Albinism

This is another inborn error of


tyrosine metabolism

It is due to absence of tyrosinase


from melanocytes

This enzyme is required for synthesis


of melanin
Melanin is not synthesized in
patients having albinism

Their skin, hair and iris become white

Such patients are called albinos


Photophobia and skin hypersensitivity are
common in albinos

The incidence of skin cancer is also high

Goggles and sunscreen lotions


can reduce the discomfort
Histidinaemia

This is an inborn error of


histidine metabolism in which histidase is
deficient

Histidine cannot be converted


into urocanic acid

Histidine concentration in plasma


is increased
Histidine is converted into some alternate
metabolites:

Imidazole pyruvate

Imidazole lactate

Imidazole acetate

The alternate metabolites are


excreted in urine
Histidinaemia was believed in the past to
impair development of speech

This later turned out to be incorrect

Most of the subjects with histidinaemia


have no symptoms
1% of the histidinaemic subjects develop
behavioural problems, learning disorders
and intellectual disability

This usually happens when histidinaemic


babies are exposed to perinatal hypoxia
Hartnup Disease

This disease was first diagnosed in the


Hartnup family

It was believed to be a disorder of


tryptophan metabolism at first

Later evidence showed a transport defect


involving all neutral amino acids
Intestinal absorption of neutral amino
acids is impaired

Renal tubular reabsorption of neutral


amino acids is also impaired

This leads to massive loss of amino


acids
Tryptophan present in gut is converted
into indole and indoxyl derivatives by
bacteria

These are absorbed and are excreted in


urine
Decreased availability of tryptophan
decreases endogenous synthesis of niacin

This may produce a pellagra-like picture

The treatment consists of a high-protein


diet and niacin supplements

You might also like